Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Market price (% of par)
-
100.45%
-
Total 13F principal
-
$243,593,220
-
Principal change
-
+$243,593,220
-
Total reported market value
-
$246,900,040
-
Number of holders
-
28
-
Value change
-
+$246,897,255
-
Number of buys
-
28
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q2 2021
As of 30 Jun 2021,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 was held by
28 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$243,593,220
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, UBS ASSET MANAGEMENT AMERICAS INC, CNH PARTNERS LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, STATE STREET CORP, SHENKMAN CAPITAL MANAGEMENT INC, LAZARD ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, and NEW YORK STATE COMMON RETIREMENT FUND.
This page lists
29
institutional bondholders reporting positions
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.